Organoid Screening Reveals Epigenetic Vulnerabilities in Human Colorectal Cancer

0
18
To gain insights into the pharmacobiology of human colorectal cancer, scientists created a robust drug screening platform for patient-derived colorectal organoids.
[Nature Chemical Biology]

Sorry, but the selected Zotpress account can't be found.

AbstractPress ReleaseGraphical Abstract